SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318154-97-000005
Filing Date
1997-03-24
Accepted
1997-03-24 00:00:00
Documents
12
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 203374
2 1991 EQUITY INCENTIVE PLAN EX-10.1 51115
3 DIRECTORS' STOCK INCENTIVE PLAN EX-10.13 21451
4 MANAGEMENT INCENTIVE PLAN EX-10.35 13077
5 AMENDMENT #5 A&R RETIREMENT AND SAVINGS PLAN EX-10.43 4742
6 AMENDMENT #2 TO A&R RETIREMENT AND SAVINGS PLAN EX-10.44 4744
7 AMENDMENT #1 TO CREDIT AGREEMENT EX-10.45 18909
8 CONSULTING AGREEMENT WITH DAN VAPNEK EX-10.48 18533
9 AGREEMENT WITH GEORGE VANDEMAN EX-10.49 4244
10 COMPUTATION OF EPS EX-11 3038
11 SUBSIDIARIES EX-21 1924
12 FINANCIAL DATA SCHEDULES EX-27 2025
  Complete submission text file 0000318154-97-000005.txt   349915
Mailing Address 1840 DEHAVILLAND DR. MAIL STOP 10-1-B-512 THOUSAND OAKS CA 91320-1789
Business Address 1840 DEHAVILLAND DR THOUSAND OAKS CA 91320-1789 0854471000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 97561520
SIC: 2836 Biological Products, (No Diagnostic Substances)